Alpha Therapeutic to Use PCR to Test for HIV, Hepatitis | GenomeWeb

NEW YORK, Sept. 24 – Alpha Therapeutic said it has received US Food and Drug Administration approval to use polymerase chain reaction technology to screen plasma donations for HIV-1 and hepatitis C.

The company, which made the announcement Friday, said it was the first company to receive such approval.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.